Transrectal high-intensity focused ultrasound devices: a critical appraisal of the available evidence.

Developments in the technology applied to the field of minimally invasive surgery have led to the exploration of high-intensity focused ultrasound (HIFU) for the treatment of localized prostate cancer. Extensive research and continuous evolution have resulted in two commercially available HIFU devices: the Ablatherm and the Sonablate500. These devices are conceptually the same; however, specific technical differences exist. This paper reviews the clinical outcomes obtained with these devices, evaluates the quality of the evidence from the individual trials, and provides the results of a head-to-head comparison in terms of oncologic outcomes and complication rates.

[1]  T. Uchida,et al.  Transrectal high‐intensity focused ultrasound for the treatment of localized prostate cancer: Eight‐year experience , 2009, International journal of urology : official journal of the Japanese Urological Association.

[2]  M. Irwin,et al.  Anaesthesia for high intensity focused ultrasound (HIFU) therapy , 2008, Anaesthesia.

[3]  P. O’Reilly,et al.  VISUALLY DIRECTED HIGH‐INTENSITY FOCUSED ULTRASOUND FOR ORGAN‐CONFINED PROSTATE CANCER: A PROPOSED STANDARD FOR THE CONDUCT OF THERAPY , 2007, BJU international.

[4]  J. Chapelon,et al.  711 PROSTATE CANCER CONTROL IN 463 PATIENTS TREATED WITH THE FIRST GENERATION HIFU MACHINE , 2007 .

[5]  A. Gelet,et al.  708 LONG-TERM RESULTS WITH HIGH INTENSITY FOCUSED ULTRASOUND (HIFU) IN 140 PATIENTS WITH LOCALIZED PROSTATE CANCER , 2007 .

[6]  Laura Curiel,et al.  Control of prostate cancer by transrectal HIFU in 227 patients. , 2007, European urology.

[7]  J. Rewcastle,et al.  High Intensity Focused Ultrasound for Prostate Cancer: A Review of the Scientific Foundation, Technology and Clinical Outcomes , 2006, Technology in cancer research & treatment.

[8]  M. Emberton,et al.  Sonablate-500: transrectal high-intensity focused ultrasound for the treatment of prostate cancer. , 2006, Expert review of medical devices.

[9]  G. Aus,et al.  Current status of HIFU and cryotherapy in prostate cancer--a review. , 2006, European urology.

[10]  P. Wild,et al.  Morbidity associated with repeated transrectal high-intensity focused ultrasound treatment of localized prostate cancer , 2006, World Journal of Urology.

[11]  J. Rosette,et al.  HIFU: Local Treatment of Prostate Cancer , 2006 .

[12]  C. Chaussy,et al.  TEN YEARS HIGH-INTENSITY FOCUSED ULTRASOUND (HIFU) AS LOCAL TREATMENT OF PROSTATE CANCER: PROFILE OF SIDE EFFECTS , 2006 .

[13]  Toyoaki Uchida,et al.  Five years experience of transrectal high‐intensity focused ultrasound using the Sonablate device in the treatment of localized prostate cancer , 2006, International journal of urology : official journal of the Japanese Urological Association.

[14]  Toyoaki Uchida,et al.  Treatment of localized prostate cancer using high‐intensity focused ultrasound , 2006, BJU international.

[15]  T. Uchida,et al.  Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer: a multicenter study. , 2005, Hinyokika kiyo. Acta urologica Japonica.

[16]  Michel Soulie,et al.  Transrectal high-intensity focused ultrasound in the treatment of localized prostate cancer. , 2005, Journal of endourology.

[17]  T. Pickles,et al.  Technology review: high-intensity focused ultrasound for prostate cancer. , 2005, The Canadian journal of urology.

[18]  Guy Vallancien,et al.  High-intensity focused ultrasound and localized prostate cancer: efficacy results from the European multicentric study. , 2003, Journal of endourology.

[19]  C. Chaussy,et al.  The status of high-intensity focused ultrasound in the treatment of localized prostate cancer and the impact of a combined resection , 2003, Current urology reports.

[20]  Narendra T. Sanghvi,et al.  Transrectal high-intensity focused ultrasound for treatment of patients with stage T1b-2n0m0 localized prostate cancer: a preliminary report. , 2002, Urology.

[21]  J. Chapelon,et al.  Transrectal High Intensity Focused Ultrasound for the Treatment of Localized Prostate Cancer: Factors Influencing the Outcome , 2001, European Urology.

[22]  P. Walsh,et al.  High-Intensity Focused Ultrasound (HIFU) Followed After One to Two Weeks by Radical Retropubic Prostatectomy: Results of a Prospective Study , 1999 .

[23]  J. Chapelon,et al.  Treatment of localised prostate cancer with transrectal high intensity focused ultrasound. , 1999, European journal of ultrasound : official journal of the European Federation of Societies for Ultrasound in Medicine and Biology.

[24]  M. Marberger,et al.  Effect of high-intensity focused ultrasound on human prostate cancer in vivo. , 1995, Cancer research.

[25]  R. Écochard,et al.  In vivo effects of high-intensity ultrasound on prostatic adenocarcinoma Dunning R3327. , 1992, Cancer research.

[26]  L. Frizzell,et al.  Localized tissue destruction by high-intensity focused ultrasound. , 1973, Archives of surgery.

[27]  A. Gelet,et al.  Principles and results of high-intensity focused ultrasound for localized prostate cancer , 2004, Prostate Cancer and Prostatic Diseases.

[28]  J M Dubernard,et al.  Treatment of prostate cancer with transrectal focused ultrasound: early clinical experience. , 1996, European urology.

[29]  W. Nyborg,et al.  Current status of research on biophysical effects of ultrasound. , 1994, Ultrasound in medicine & biology.